Breaks Categories: News

FridayDec 27, 2024 12:16 pm

HempNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods

WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S., today reviewed highlights and announced future plans in a letter to shareholders. In addition to outlining multiple accomplishments from 2024, the company indicated that it intends “to expand into ‘consumer packaged goods’ utilizing our rare Landrace strains including Original Panama Red, Acapulco Gold, Red Bud Colombian, Santa Marta Gold, African Ebony, Jamaican, Thai (ThaiSticks) and Andalusian Nepalese (remember Temple Balls - Hash),” the letter reads. “As your president and CEO, I’m so very grateful for your support and patience as our team at WEED moves…

Continue Reading

TuesdayDec 17, 2024 2:58 pm

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct

Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate purchase and sale of approximately $3.6 million of Common Shares, each at a price of $1.25. Flora announced approximately $3.6 million in expected aggregate gross proceeds from the offering, of which it intends to use the net, together with existing cash, for general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent for the offering. Dorsey & Whitney LLP acted as counsel to the company, and Kaufman & Canoles P.C. acted as counsel to Aegis Capital Corp. To view the full…

Continue Reading

ThursdayNov 21, 2024 11:30 am

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Host Spaces Event, Share Comprehensive Update on Destino Ranch

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call at 1:30 p.m. PST on Wednesday, Dec. 11, 2024, on the company’s official X account, @GTV_Inc. Steffan Dalsgaard, president of Golden Triangle Ventures and CEO of Lavish Entertainment, alongside Marco Moreno, president of Lavish Entertainment, will lead the event and deliver a comprehensive update on the company’s transformative flagship project — Destino Ranch. GTV’s wholly owned subsidiary Lavish Entertainment is spearheading the development of Destino Ranch, which is poised to become a world-renowned destination and premier experiential hospitality and entertainment venue, including immersive art installations,…

Continue Reading

ThursdayOct 24, 2024 12:45 pm

HempNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry

CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70 billion industry and, with its innovative product line and strategic market positioning, standing ready to deliver unparalleled returns for shareholders. “The U.S. is on the verge of a historic shift. With the Biden administration, led by Vice President Kamala Harris, taking bold steps toward federal marijuana legalization, the opportunities for companies in the cannabis and CBD sectors are poised to skyrocket,” the announcement reads. “According to industry projections, the legal cannabis market in the U.S. is expected to surpass $70 billion by 2028, driven by…

Continue Reading

FridaySep 27, 2024 3:20 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that it had received approval from an independent review board for its planned human pilot study #3. The approval signals that the company can begin the study, which aims to investigate the first ever DehydraTECH-processed version of tirzepatide, a dual action glucagon-like peptide (“GLP-1”) + glucose-dependent insulinotropic peptide (“GIP”), in an oral dose format. Tirzepatide is approved for use in the U.S. under the Eli Lilly(TM)-owned Zepbound(R) and Mounjaro(R) brands. Lexaria plans to begin subject enrollment shortly, with the company expecting to make an announcement as…

Continue Reading

FridaySep 20, 2024 1:21 pm

HempNewsBreaks – Cannabis Conference and Expo Creates Key Opportunity for Cannabis Innovation to Meet Cannabis Community

Cannabis Conference and Expo: Grow Up 2024 will be held in Edmonton, Alberta, later this month. The three-day event is slated for Sept. 29–Oct. 1, 2024, and will bring together top growers, the largest cannabis brands and thousands of delegates for an invaluable conference and trade show designed to provide key information about relevant topics in the cannabis industry. The event is Canada’s largest conference and expo. The event agenda features an exclusive riverboat kick-off party, expo days, a Canadian cannabis championship, an array of addresses, panel presentations and workshops by industry experts and an insightful interview with legendary cannabis…

Continue Reading

ThursdaySep 12, 2024 2:08 pm

HempNewsBreaks – CannabisNewsWire and IBN Partner with NY Cannabis Insider to Boost Visibility for Premier Cannabis Event

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 65+ brands powered by IBN, on Thursday announced that it has been named the Official NewsWire of the NY Cannabis Insider event, with IBN serving as the Official Media Sponsor. The event, scheduled for September 25, 2024, at The Desmond Hotel in Albany, NY, will focus on "Making Money in the Legal NYS Market," featuring industry leaders sharing insights on building profitable cannabis businesses. CNW will amplify the event’s coverage through its vast syndication network, while IBN will drive visibility across its family of brands. This…

Continue Reading

ThursdaySep 12, 2024 12:05 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Partnership to Boost Operational Capacity, Sustain Revenue Growth in Logistics Division

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today announced a strategic partnership between LE Logistics, LLC, its wholly owned subsidiary, and West End Trucking, Inc. The partnership is expected to significantly boost the company’s asset base and operational capacity and set the stage for continued revenue growth and long-term success. Under the partnership, LE Logistics will manage and operate a fleet of 13 trucks and trailers under its own and West End’s licenses. Specifically, LE Logistics will handle all day-to-day logistics operations and create a robust system for fleet management, while West End will ensure compliance with all…

Continue Reading

ThursdaySep 05, 2024 11:16 am

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints Medical Device and Pharmaceutical Industries Veteran as New CEO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of Richard Christopher as the new CEO, effective August 31, 2024. Mr. Christopher is a recognized industry veteran with over three decades of experience in the medical device and pharmaceutical industries. He has domestic and international experience in leadership, operations, acquisitions/licensing, business development, strategic planning and capital markets. Mr. Christopher takes over from outgoing CEO, Chris Bunka, who has stepped aside from the role. Mr. Bunka remains as the Chairman of the Board of Directors and has been appointed Executive Strategic Advisor to the…

Continue Reading

TuesdaySep 03, 2024 12:24 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Material Transfer Agreement to Evaluate DehydraTECH(TM) Technology in Pre-Clinical Setting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has entered into a Materials Transfer Agreement with a pharmaceutical company. Under the terms of the agreement, the pharmaceutical company will evaluate Lexaria’s DehydraTECH(TM) technology in a pre-clinical setting. Lexaria will be responsible for formulating and supplying certain DehydraTECH compositions, with the pharmaceutical company evaluating the pharmacokinetics of these compositions in animal studies. According to the company, Lexaria has awarded the pharmaceutical company a temporary exclusive license option limited to specific DehydraTECH concepts and formulations under examination. The work is expected to be completed within roughly 6 months…

Continue Reading